CHICAGO, July 19, 2017 -- tronc, Inc. (NASDAQ:TRNC) will report its financial results for the second quarter ended June 25, 2017 on Wednesday, August 2, 2017 after the market closes.
The announcement will be followed by a conference call to discuss the company’s business and financial results at 5 p.m. Eastern Time (4 p.m. Central Time). The conference call may be accessed via tronc’s Investor Relations website at investor.tronc.com or by dialing 844.494.0195 (508.637.5599 for international callers) and entering conference ID 56167153. An archived version of the webcast will also be available for one year on the tronc website. To access the replay via telephone, available until August 9, 2017, dial 855.859.2056 (404.537.3406 for international callers), conference ID 56167153.
About tronc, Inc.
tronc, Inc. (NASDAQ:TRNC) is a media company rooted in award-winning journalism, operating over 160 titles in nine of the nation's largest markets. tronc’s respected brands have earned a combined 94 Pulitzer Prizes. tronc develops unique and valuable content across its vast media portfolio and is committed to informing and inspiring a growing monthly audience of 59 million. For more information, visit www.tronc.com.
Contact: Aaron Miles tronc Investor Relations 312.222.4345 [email protected] or Marisa Kollias tronc Corporate Communications 312.222.3308 [email protected]


California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 



